Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-15 Purchase | 2023-11-17 4:01 pm | Gossamer Bio Inc. | GOSS | Milligan Sandra Director | 32,000 | $0.7879 | $25,213 | 32,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-12 Option Award | 2024-11-13 8:54 pm | 2024-11-12 2034-11-12 | Aspira Women's Health Inc. | AWH | Milligan Sandra President | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-10-28 Option Award | 2024-10-28 6:54 pm | N/A N/A | Aspira Women's Health Inc. | AWH | Milligan Sandra President | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-06 9:58 pm | N/A 2034-06-05 | Gossamer Bio Inc. | GOSS | Milligan Sandra Director | 115,000 | $0 | 115,000 (Direct) | View |
| 2024-05-14 Option Award | 2024-05-16 4:10 pm | N/A 2034-05-14 | Spyre Therapeutics Inc. | SYRE | Milligan Sandra Director | 21,980 | $0 | 21,980 (Direct) | View |
| 2024-05-03 Option Award | 2024-05-06 6:49 pm | N/A 2034-05-03 | Aspira Women's Health Inc. | AWH | Milligan Sandra President | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 4:14 pm | N/A 2033-06-07 | Gossamer Bio Inc. | GOSS | Milligan Sandra Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-05-04 Exercise | 2023-05-08 6:43 pm | 2023-05-04 2024-05-04 | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 4,984 | $0 | 33,583 (Direct) | View |
| 2023-05-04 Tax Withholding | 2023-05-08 6:43 pm | N/A N/A | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 2,168 | $24.24 | 33,583 (Direct) | View |
| 2023-05-01 Exercise | 2023-05-03 7:06 pm | 2023-05-01 2023-05-01 | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 1,899 | $0 | 25,783 (Direct) | View |
| 2023-05-01 Tax Withholding | 2023-05-03 7:06 pm | N/A N/A | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 826 | $24.63 | 25,783 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 8:18 pm | N/A N/A | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 5,964 | $0 | 170,829 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-04 8:18 pm | 2024-03-31 2026-03-31 | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 134,191 | $0 | 170,829 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 8:18 pm | N/A N/A | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 2,115 | $23.09 | 170,829 (Direct) | View |
| 2023-02-28 Tax Withholding | 2023-03-02 5:29 pm | N/A N/A | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 2,346 | $25.09 | 20,861 (Direct) | View |
| 2023-02-28 Exercise | 2023-03-02 5:29 pm | 2022-12-31 2022-12-31 | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 7,976 | $0 | 20,861 (Direct) | View |
| 2022-06-09 Option Award | 2022-07-15 5:03 pm | N/A 2032-06-08 | Gossamer Bio Inc. | GOSS | Milligan Sandra Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-05-03 Exercise | 2022-05-05 8:47 pm | 2022-05-03 2022-05-03 | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 6,826 | $0 | 22,057 (Direct) | View |
| 2022-05-04 Tax Withholding | 2022-05-05 8:47 pm | N/A N/A | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 1,806 | $32.44 | 22,057 (Direct) | View |
| 2022-05-03 Tax Withholding | 2022-05-05 8:47 pm | N/A N/A | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 525 | $32.08 | 22,057 (Direct) | View |
| 2022-05-01 Tax Withholding | 2022-05-03 7:40 pm | N/A N/A | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 540 | $32.33 | 12,632 (Direct) | View |
| 2022-05-01 Exercise | 2022-05-03 7:40 pm | 2022-05-01 2023-05-01 | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 1,896 | $0 | 12,632 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 6:06 pm | 2023-03-31 2025-03-31 | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 73,006 | $0 | 73,006 (Direct) | View |
| 2022-02-28 Exercise | 2022-03-02 6:46 pm | 2021-12-31 2021-12-31 | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 10,171 | $0 | 9,380 (Direct) | View |
| 2022-02-28 Tax Withholding | 2022-03-02 6:46 pm | N/A N/A | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 2,941 | $37.57 | 9,380 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-19 5:14 pm | 2022-08-17 2031-08-16 | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 22,321 | $0 | 22,321 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 5:26 pm | N/A 2031-06-09 | Gossamer Bio Inc. | GOSS | Milligan Sandra Director | 47,000 | $0 | 47,000 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 9:27 pm | 2022-05-03 2022-05-03 | Organon & Co. | OGN | Milligan Sandra Head of Research & Development | 426,542 | $0 | 428,692 (Direct) | View |